Athira Pharma's Regulatory Compliance Challenges Threaten Drug Development Pipeline

TipRanksNov 9 14:01

Althira Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.

BenzingaNov 9 02:34

JMP Securities Maintains Athira(ATHA.US) With Hold Rating

Futu NewsNov 8 14:31 · Ratings

Athira Pharma Reports Q3 2024 Financial Results

TipRanksNov 8 14:02

JMP Securities Keeps Their Hold Rating on Athira Pharma (ATHA)

TipRanksNov 8 13:36 · Ratings

Athira | 10-Q: Q3 2024 Earnings Report

SECNov 8 05:24 · Announcements